Učitavanje...

Novel combinations to improve hematopoiesis in myelodysplastic syndrome

Myelodysplastic syndrome (MDS) represents a heterogeneous group of clonal hematopoietic disorders, which is characterized by cytopenias in the peripheral blood and bone marrow dysplasia due to ineffective hematopoiesis. Patients with MDS have an increased risk of transformation to acute myeloid leuk...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Stem Cell Res Ther
Glavni autori: Syed, Khaja, Naguib, Sara, Liu, Zhao-Jun, Cimmino, Luisa, Yang, Feng-Chun
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083030/
https://ncbi.nlm.nih.gov/pubmed/32197634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01647-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!